Adenosine metabolism in platelets and plasma.
D000241:Adenosine / Q000097:blood*; D000244:Adenosine Diphosphate / Q000494:pharmacology*; D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology; D001665:Binding Sites / Q000187:drug effects; D001772:Blood Cell Count; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D002021:Buffers; D002250:Carbon Radioisotopes; D002499:Centrifugation, Density Gradient; D003864:Depression, Chemical; D004176:Dipyridamole / Q000494:pharmacology; D006168:Guinea Pigs; D006801:Humans; D007042:Hypoxanthines / Q000494:pharmacology; D007288:Inosine / Q000494:pharmacology; D008094:Lithium / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011453:Prostaglandins / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D011955:Receptors, Drug; D013045:Species Specificity; D013696:Temperature; D013997:Time Factors; D014527:Uric Acid / Q000494:pharmacology
D000925:Anticoagulants; D002021:Buffers; D002250:Carbon Radioisotopes; D007042:Hypoxanthines; D011453:Prostaglandins; D011955:Receptors, Drug; D014527:Uric Acid; D007288:Inosine; D000244:Adenosine Diphosphate; D004176:Dipyridamole; D008094:Lithium; D000241:Adenosine